Investment in tourism continues on the upswing in the Riviera Nayarit, this time with Marriott International. The company recently announced the opening of four new hotels in the destination under the all-inclusive format, a first for the brand.
During an interview for a national publication, Marriott announced an $800 million investment in five new hotels—the four mentioned earlier, plus another property in Punta Cana, for a total inventory of two thousand rooms. The Riviera Nayarit will welcome 1,440 of those rooms.
Laurent de Kousemaeker, Chief Development Officer for Marriott International, Caribbean and Latin American Region, added that the new properties will be located within a complex named NIA. This development is owned by Mexican investment fund Artha Capital, with participation in infrastructure, energy, and tourism.
NIA has an extension of 90 hectares with a kilometer of beachfront where the company will build a 400-room Westin Hotels resort and a 240-room The Ritz-Carlton resort, both programmed to open in 2023.
The company will also build an Autograph Collection hotel with 300 rooms and a 500-room Marriott Hotel, both expected to be in operation by 2025.
Gerardo Fernández, Managing Director for Artha Capital’s Hospitality Platform, added via a press release:
“We’re very excited to be working with Marriott International to create and inaugurate a one-of-a-kind vacation destination in Mexico’s Riviera Nayarit that will include four of the company’s most recent and unique brand experiences.”
The Riviera Nayarit Convention and Visitors Bureau (CVB) and the Bahía de Banderas Hotel and Motel Association (AHMBB) consider these new investments to be a result of the dedicated tourism promotion in place since the launch of the Riviera Nayarit brand, which has positioned the destination at top-of-mind with national and international travelers.
Marriott International currently has two properties in the Riviera Nayarit: The St. Regis Punta Mita Resort and W Punta de Mita, with 130 and 119 rooms, respectively. In December 2018, the company signed the Ritz-Carlton Reserve project within the master development plan in Costa Canuva.
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More